Who invested in Engimmune?
2 investors are on record as having backed Engimmune — Develops T-cell receptor drugs for cancer, in Biotech, Switzerland. Each row below says whether the round came from the investor's own portfolio page or from the press.
engimmune.comEngimmune investors
BaseLaunchPartners with scientists and entrepreneurs to launch biotech ventures developing…their site
Pureos BioventuresVenture capital for private companies developing next-generation biological drugs and…their site
No round dates are on record for Engimmune. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Engimmune are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.